Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    Sodium arsenite
Show Display Options
Rank Status Study
1 Recruiting Trial Of Cisplatin And KML-001 in Platinum Responsive Malignancies
Conditions: Non-Small Cell Lung Cancer, Small Cell Lung Cancer;   Platinum Responsive Malignancies
Interventions: Drug: KML-001;   Drug: Cisplatin

Indicates status has not been verified in more than two years